How to Address the IP Issues Specifically Associated with Polymorphic Forms



Pharma IQ
09/28/2010

It is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutical products are crystalline forms which, due to the intricacies of obviousness and novelty, are notoriously difficult to patent and litigate. In this podcast Dr. Alpesh Pathak, Head - Patent Cell at Alembic Research Center, shares his insights with Andrea Charles from Pharma IQ, regarding the IP...
TO READ THE FULL STORY